EHR Impact Study Findings: Interoperability, long-term strategic focus, good management essential to realize eventual benefit from investment

There is very little evidence on which to base EHR implementation investment decisions. Fortunately, that is changing. Findings from the recently released EHR Impact study: The Socio-Economic Impact of Interoperable Electronic Health Record (EHR) and Eprescribing Systems in Europe and Beyond, show that EHRs and ePrescribing are not quick wins, but they are sustainable wins. An important finding was that interoperability is a prime driver of benefits from EHR and ePrescribing systems as benefits rely on access to information regardless of place and time. Local, closed ICT systems lacking interoperability would not release these substantial gains. Extremely important to success of such investments, also, is the skill and expertise of executives and managers in managing organisational change and resource redeployment.

The Value and Impact of Electronic Health Records: What evidence?

Although electronic health systems hold great promise, there are still barriers to adoption that includethe cost of purchasing a system, defining needs and customizing a system to meet those needs, uncertainty about the return on investment, and concern about meeting future needs (scalability, compatibility with other systems, ability to add functionality). What evidence is there to evaluate what system to invest in, best practices in implementation, and how to measure return on investment across an organization? This post discusses some available evidence.